Engineered streptomyces platensis strains that overproduce antibiotics platensimycin and platencin

92Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Platensimycin, which is isolated from Streptomyces platensis MA7327, and platencin, which is isolated from S. platensis MA7339, are two recently discovered natural products that serve as important antibiotic leads. Here we report on the identification of S. platensis MA7327 as a dual producer of both platensimycin and platencin. A PCR-based approach was used to locate and clone the locus involved in platensimycin and platencin production, including ptmRl, which encodes a putative GntR-like transcriptional regulator. Deletion of this gene from the producing organism allowed us to isolate strains that overproduce platensimycin and platencin with yields of 323 ± 29 mg/liter and 255 ± 30 mg/liter, respectively. These results illustrate the effectiveness of genetic manipulation for the rational engineering of improvements in titers. Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Smanski, M. J., Peterson, R. M., Rajski, S. R., & Shen, B. (2009). Engineered streptomyces platensis strains that overproduce antibiotics platensimycin and platencin. Antimicrobial Agents and Chemotherapy, 53(4), 1299–1304. https://doi.org/10.1128/AAC.01358-08

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free